Market Place
Sourcing Support
Ocugen Update Charts Course For Rivalry With Apellis, Astellas
16 Jan 2026 //
FIERCE BIOTECH
Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug
16 Jan 2026 //
ECONOMICTIMES
Zydus Lifesciences Completes the Acquisition of Agenus Facility
16 Jan 2026 //
PR NEWSWIRE
Sun Pharma Announces UNLOXCYT for Advanced aCSCC Carcinoma
16 Jan 2026 //
PR NEWSWIRE
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
16 Jan 2026 //
FIERCE PHARMA
Myqorzo And Redemplo Approved In China
16 Jan 2026 //
PRESS RELEASE
Novo Foundation Invests $860M To Nurture Homegrown Biotechs
16 Jan 2026 //
FIERCE BIOTECH
FDA Delays Decision On Lilly's Obesity Drug Orforglipron
16 Jan 2026 //
REUTERS
Boston Scientific To Snap Up Penumbra In Deal Valued At $14.5B
16 Jan 2026 //
PR NEWSWIRE
Extendicare Announces January 2026 Dividend Of C$0.042 Per Share
15 Jan 2026 //
GLOBENEWSWIRE
Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug
16 Jan 2026 //
ECONOMICTIMES
Altanine's Outlook on Generics and Value-Added Formulations
14 Jan 2026 //
GLOBENEWSWIRE
Dr. Reddy's Announces First-to-Market Launch of Olopatadine HCl
14 Jan 2026 //
PRESS RELEASE
Bionpharma Gets USFDA Nod For Etravirine Tablets With Steerlife
13 Jan 2026 //
PR NEWSWIRE
Allos Secures $5M For Causal AI In Drug Reformulation
12 Jan 2026 //
PR NEWSWIRE
Alembic Announces USFDA Tentative Approval For Bosutinib Tablets
12 Jan 2026 //
INDPHARMAPOST
Biocon Arm Gets USFDA Nod For Generic Everolimus Tablets
12 Jan 2026 //
ECONOMICTIMES
ChemWerth Appoints New GSM to Expand India Generic API Reach
12 Jan 2026 //
PRESS RELEASE
FDA Confirms Para IV Patent Litigation for Brukinsa
09 Jan 2026 //
FDA
FDA Confirms Para IV Patent Litigation for Livtencity
09 Jan 2026 //
FDA
Ocugen Update Charts Course For Rivalry With Apellis, Astellas
16 Jan 2026 //
FIERCE BIOTECH
Zydus Lifesciences Completes the Acquisition of Agenus Facility
16 Jan 2026 //
PR NEWSWIRE
Sun Pharma Announces UNLOXCYT for Advanced aCSCC Carcinoma
16 Jan 2026 //
PR NEWSWIRE
Novo Foundation Invests $860M To Nurture Homegrown Biotechs
16 Jan 2026 //
FIERCE BIOTECH
Viromissile Appoints Michael G. Wood As Chief Business Officer
15 Jan 2026 //
GLOBENEWSWIRE
Liberation Bioindustries Announces New Roles For Founders
15 Jan 2026 //
GLOBENEWSWIRE
Wuxi Biologics Launches Patrolab Digital Twin Platform
15 Jan 2026 //
INDPHARMAPOST
Vaxart Releases Positive Data On Oral Norovirus Vaccine
15 Jan 2026 //
GLOBENEWSWIRE
Kelun-Biotech Highlights Innovations And Strategy At JPM Conf
15 Jan 2026 //
PR NEWSWIRE
Serina Pharma Notified Of NYSE Deficiency On Shareholders' Equity
15 Jan 2026 //
GLOBENEWSWIRE
Agno Pharma Acquires Actylis's CDMO Manufacturing Asset
15 Jan 2026 //
BUSINESSWIRE
Life Sciences Industry Urges Cybersecurity Funding, PLI Policy
14 Jan 2026 //
PHARMABIZ
Pharma, Med-Tech Firms Seek PLI Extension For APIs Coverage 2026
10 Jan 2026 //
ECONOMICTIMES
Supriya Lifescience Boosts Capacity And Global Readiness
08 Jan 2026 //
EXPRESS PHARMA
How to Choose a Reliable Oxytetracycline HCL API Manufacture
08 Jan 2026 //
PRESS RELEASE
Understanding Sevelamer Carbonate API COA Parameters
08 Jan 2026 //
PRESS RELEASE
GMP Manufacturing Challenges in Tadalafil API Production
08 Jan 2026 //
PRESS RELEASE
Understanding Latanoprost API COA Parameters
08 Jan 2026 //
PRESS RELEASE
Government Eyes Separate Licensing for Bulk Drugs
07 Jan 2026 //
EXPRESSPHARMA
Telangana Pharma Companies To Discuss Lalitpur Bulk Drugs Park
06 Jan 2026 //
PHARMABIZ
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
16 Jan 2026 //
FIERCE PHARMA
Experts Urge Scrutiny of Fake ISO Certs for Medical Devices
15 Jan 2026 //
PHARMABIZ
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
15 Jan 2026 //
BIOSPACE
IPA-CPD Urges Health Ministry To Mandate Red Line On Antibiotic
14 Jan 2026 //
PHARMABIZ
Jharkhand DCA Seeks Correction on CDL Kolkata Cough Syrup Report
14 Jan 2026 //
PHARMABIZ
FDA Issues First Two Untitled Letters In 2026 Enforcement Drive
14 Jan 2026 //
RAPS
Nestle Steps up Infant Formula Damage Limitation
14 Jan 2026 //
REUTERS
Delhi HC Restores Ban On 2 Diabetes FDCs
14 Jan 2026 //
ECONOMICTIMES
DoP May Exempt 11 More Drugs from Global Tenders
13 Jan 2026 //
PHARMABIZ
India Cracks Down on Toxic Contaminants in Kids' Medicines
13 Jan 2026 //
PHARMABIZ
Mount Sinai Become 1st in Metro New York to Deliver Incision-Free
15 Jan 2026 //
GLOBENEWSWIRE
R1 Prior Auth with Phare OS Speeds Care, Cuts Costs
15 Jan 2026 //
GLOBENEWSWIRE
IHCL To Aquire 51% Stake In Brij Hospitality
15 Jan 2026 //
ECONOMICTIMES
Pharma Trends: Building a Future-Ready, Patient-Centric Industry
15 Jan 2026 //
EXPRESSPHARMA
EndoQuest Receives FDA Approval to Final Stage of PARADIGM Trial
15 Jan 2026 //
BUSINESSWIRE
IDEXX Enhances Canine Cancer Care With Mast Cell Tumor Testing
15 Jan 2026 //
BUSINESSWIRE
ERMA Systems Launches Q1 AI Pilot with Life Sciences Leaders
15 Jan 2026 //
BUSINESSWIRE
Quantipath Introduces Expanded À La Carte Multiplex Options
15 Jan 2026 //
PR NEWSWIRE
14th Annual State of Cure for T1D Shows Development in Research
15 Jan 2026 //
GLOBENEWSWIRE
Hyperfine Enrolls First Patient To Expand Swoop System Use
15 Jan 2026 //
BUSINESSWIRE
Santhera Secures Swissmedic Approval for AGAMREE in DMD
15 Jan 2026 //
GLOBENEWSWIRE
JPM Day 3: Rare Disease In The Spotlight
15 Jan 2026 //
BIOSPACE
Adolore BioTherapeutics Receives FDA Orphan Drug Designation
14 Jan 2026 //
ACCESSWIRE
Genethon Licenses Askbio For Pompe Disease Gene Therapy
14 Jan 2026 //
BUSINESSWIRE
Keenova To Showcase Live Dupuytren's Contracture Treatment
14 Jan 2026 //
PR NEWSWIRE
Solid Bio Highlights 2026 Neuromuscular Pipeline For AAV-SLB101
13 Jan 2026 //
GLOBENEWSWIRE
Kye Pharma Licenses SLENYTO from Neurim for Canadian Market
13 Jan 2026 //
PR NEWSWIRE
FDA Grants Ipsen BTD for IPN60340 in Acute Myeloid Leukemia
13 Jan 2026 //
GLOBENEWSWIRE
Orsini Selected as Pharmacy Partner for Cytokinetics's MYQORZO
13 Jan 2026 //
PR NEWSWIRE
Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
13 Jan 2026 //
PHARMIWEB
Myqorzo And Redemplo Approved In China
16 Jan 2026 //
PRESS RELEASE
FDA Delays Decision On Lilly's Obesity Drug Orforglipron
16 Jan 2026 //
REUTERS
Boston Scientific To Snap Up Penumbra In Deal Valued At $14.5B
16 Jan 2026 //
PR NEWSWIRE
Extendicare Announces January 2026 Dividend Of C$0.042 Per Share
15 Jan 2026 //
GLOBENEWSWIRE
Sienna Announces January Dividend
15 Jan 2026 //
GLOBENEWSWIRE
Precipio Takes Major Steps Toward A Clean Balance Sheet
15 Jan 2026 //
GLOBENEWSWIRE
JPM26: Verizon Outage Unites Directionless Conference Goers
15 Jan 2026 //
BIOSPACE
11 Companies Hiring Manufacturing Professionals Now
15 Jan 2026 //
BIOSPACE
Trump Targets Insurers, Drug Prices In 'Great Healthcare Plan'
15 Jan 2026 //
FIERCE PHARMA
Hologic Sets A Screen To Block Cervical Cancer With WNBA Star
15 Jan 2026 //
FIERCE PHARMA
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.